PD-1 对小鼠内毒素血症的保护作用及其机制研究

摘要
图/表
参考文献(21)
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (952 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要目的：革兰阴性细菌感染所致的多器官衰竭/功能障碍综合征仍是目前发达国家和发展中国家儿童死亡的主要原因之一，发病机制尚不明确。本研究探讨了具有负性免疫调节作用的免疫球蛋白超家族的成员程序性死亡受体-1（programmed death-1，PD-1）对革兰阴性细菌的主要致病成分脂多糖（LPS）所致内毒素血症的保护作用及可能的相关机制。方法PD-1+/+和PD-1/小鼠各10只经腹腔注射LPS（10 mg/kg）,观察其 72 h 存活情况；另对PD-1+/+和PD-1/小鼠各40只经腹腔注射LPS（5 mg/kg），分别在注射前（0 h）及注射后1.5、3、6 h 采血，用ELISA检测血浆中多种炎性成分的含量。结果PD-1/小鼠在接受大剂量 LPS注射后，存活率明显低于PD-1+/+小鼠。注射5 mg/kg LPS后，PD-1/小鼠生成的具有促炎作用的介质TNF-α、IL-1β、IL-12及IL-17高于PD-1+/+小鼠。结论 PD-1对LPS所致的内毒素血症具有保护作用，可能是通过调节炎性成分的生成来实现的。［中国当代儿科杂志，2010，12(10)：812-815］

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	杨丽芬
	何芳
	章坚
	尹飞

关键词 ：内毒素血症, 基因敲除, 程序性死亡受体-1, 小鼠

Abstract：OBJECTIVE: Gram-negative bacteria-induced multiple organ failure/dysfunction syndrome (MOF/MODS) is one of the leading causes of death through the world. The member of immunoglobulin family programmed death-1 (PD-1) is a negative immune regulator. This study investigated the protective effect of PD-1 as well as the underlying mechanism in LPS-induced endotoxemia. METHODS: Ten PD-1+/+ and ten PD-1 knockout (PD-1/) mice were injected peritoneally with LPS (10 mg/kg), and the survival was observed within 72 hrs after LPS injection. The other 40 PD-1+/+ and 40 PD-1/mice were injected peritoneally with LPS (5 mg/kg). Blood samples were collected before injection and 1.5, 3 and 6 hrs after LPS injection (n=10 each time point). Serum levels of various inflammatory mediators were measured using ELISA. RESULTS: The survival rate in PD-1/mice was noticeably lower than that in PD-1+/+ mice after 10 mg/kg LPS injection. Serum levels of inflammatory mediators TNF-α, IL-1β, IL-12 and IL-17 in PD-1/mice were higher than those in PD-1+/+ mice after 5 mg/kg LPS injection. CONCLUSIONS: PD-1 can protect mice from LPS-induced endotoxemia probably through its regulation on inflammatory mediator production.［Chin J Contemp Pediatr, 2010, 12 (10):812-815］

Key words： Gene knockout Endotoxemia Programmed death-1 Mice

PACS:

R-33

引用本文:

杨丽芬,何芳,章坚等. PD-1 对小鼠内毒素血症的保护作用及其机制研究[J]. 中国当代儿科杂志, 2010, 12(10): 812-815.

YANG Li-Fen,HE Fang,ZHANG Jian et al. Protection of PD-1 against LPS-induced endotoxemia and the underlying mechanism[J]. CJCP, 2010, 12(10): 812-815.

链接本文:

http://www.zgddek.com/CN/ 或 http://www.zgddek.com/CN/Y2010/V12/I10/812

	［1］Annane D, Bellissant E, Cavaillon JM. Septic shock ［J］. Lancet, 2005, 365 (9453): 63-78.
	［2］Karima R, Matsumoto S, Higashi H, Matsushima K. The molecular pathogenesis of endotoxic shock and organ failure ［J］. Mol Med Today, 1999, 5 (3): 123-132.
	［3］Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity ［J］. Annu Rev Immunol, 2008, 26: 677-704.
	［4］Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection ［J］. Nat Immunol, 2007, 8 (3): 239-245.
	［5］Nishimura H, Honjo T. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance ［J］. Trends Immunol, 2002, 22 (5): 265-268.
	［6］Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor ［J］. Immunity, 1999, 11 (2): 141-151.
	［7］Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice ［J］. Nat Med, 2003, 9 (12): 1477-1483.
	［8］Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice ［J］. Science, 2001, 291(5502): 319-322.
	［9］Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, Manson ME, et al. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock ［J］. J Exp Med, 2006, 203 (1): 131-140.
	［10］Bachmaier K, Toya S, Gao X, Triantafillou T, Garrean S, Park GY, et al. E3 ubiquitin ligase Cblb regulates the acute inflammatory response underlying lung injury ［J］. Nat Med, 2007, 13(8): 920-926.
	［11］Wynn J, Cornell TT, Wong HR, Shanley TP, Wheeler DS. The host response to sepsis and developmental impact ［J］. Pediatrics, 2010, 125 (5): 1031-1041.
	［12］Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria ［J］. N Engl J Med, 2010, 362 (19): 1804-1813.
	［13］Gioannini TL, Weiss JP. Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells ［J］. Immunol Res, 2007, 39 (1-3): 249-260.
	［14］Janeway CA Jr, Medzhitov R. Innate immune recognition ［J］. Annu Rev Immunol, 2002, 20: 197-216.
	［15］郭萌, 李冠民, 黄清泉. 细菌内毒素研究进展［J］. 中国实验动物学报, 2009, 17(5): 397-401.
	［16］陈洁, 姜虹. TLR4信号通路与炎性反应［J］. 医学综述, 2009,15(19): 2902-2904.
	［17］Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death ［J］. EMBO J, 1992, 11 (11): 3887-3895.
	［18］Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance ［J］. Trends Immunol, 2006, 27 (4): 195-201.
	［19］Prokunina L, Padyukov L, Bennet A, de FU, Wiman B, Prince J, et al. Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope ［J］. Arthritis Rheum, 2004, 50 (6): 1770-1773.
	［20］Nielsen C, Hansen D, Husby S, Jacobsen BB, Lillevang ST. Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes ［J］. Tissue Antigens, 2003, 62 (6): 492-497.
	［21］Kong EK, Prokunina-Olsson L, Wong WH, Lau CS, Chan TM. AlarconRiquelme M, et al. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese ［J］. Arthritis Rheum, 2005, 52 (4): 1058-1062.